AI-generated summary
The authors report on gold nanocages carrying the photosensitizer HPPH, tested for image-guided photodynamic therapy in a mouse tumor model. They describe greater drug accumulation in tumors, more singlet oxygen generation, and stronger tumor growth suppression than free drug, with no toxicity seen in a short-term study. The work is preclinical, so findings in animals may not apply to people.
- Who or what was studied
- Mice with implanted tumors (murine model)
- Limits stated in the abstract
- The study is preclinical in a murine model and the toxicity assessment was short-term.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on thno.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.